{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:23:32Z","timestamp":1792664612970,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030B_182834"],"award-info":[{"award-number":["310030B_182834"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_204835"],"award-info":[{"award-number":["310030_204835"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["NRP-78"],"award-info":[{"award-number":["NRP-78"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["4078P0_198470"],"award-info":[{"award-number":["4078P0_198470"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.coi.2025.102656","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:45:09Z","timestamp":1757609109000},"page":"102656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Skin manifestations of SARS-CoV-2 infection and its vaccination"],"prefix":"10.1016","volume":"97","author":[{"given":"Fanny","family":"Saidoune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Yatim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Di Domizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4609-3762","authenticated-orcid":false,"given":"Michel","family":"Gilliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2025.102656_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.587269","article-title":"SARS-CoV-2: structure, biology, and structure-based therapeutics development","volume":"10","author":"Wang","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.coi.2025.102656_bib2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2025.102656_bib3","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201387","article-title":"SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4","volume":"218","author":"Onodi","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102656_bib4","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021109622","article-title":"TLR2 and TLR7 mediate distinct immunopathological and antiviral plasmacytoid dendritic cell responses to SARS-CoV-2 infection","volume":"41","author":"van der Sluis","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.coi.2025.102656_bib5","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2025.102656_sbref6","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102656_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108628","article-title":"MDA5 governs the innate immune response to SARS-CoV-2 in lung epithelial cells","volume":"34","author":"Yin","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2025.102656_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41590-021-01091-0","article-title":"Innate immunity: the first line of defense against SARS-CoV-2","volume":"23","author":"Diamond","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102656_bib9","first-page":"178","article-title":"Innate immune evasion strategies of SARS-CoV-2","volume":"21","author":"Minkoff","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coi.2025.102656_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41586-022-04447-0","article-title":"Human genetic and immunological determinants of critical COVID-19 pneumonia","volume":"603","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102656_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105475","article-title":"An ultra-early, transient interferon-associated innate immune response associates with protection from SARS-CoV-2 infection despite exposure","volume":"111","author":"Fenn","year":"2025","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coi.2025.102656_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-36140-9","article-title":"Severe COVID-19 patients have impaired plasmacytoid dendritic cell-mediated control of SARS-CoV-2","volume":"14","author":"Venet","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102656_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009878","article-title":"Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection","volume":"17","author":"Severa","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2025.102656_bib14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1126\/science.abc6261","article-title":"Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans","volume":"369","author":"Arunachalam","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102656_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2025.102656_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abh2624","article-title":"Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19","volume":"13","author":"van der Wijst","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2025.102656_sbref17","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41586-022-04421-w","article-title":"The cGAS-STING pathway drives type I IFN immunopathology in COVID-19","volume":"603","author":"Domizio","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102656_bib18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev.immunol.23.021704.115843","article-title":"Type I interferons (alpha\/beta) in immunity and autoimmunity","volume":"23","author":"Theofilopoulos","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2025.102656_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2025.102656_bib20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.ASW.0000819776.56007.18","article-title":"Angiotensin-converting enzyme 2 expression is detectable in keratinocytes, cutaneous appendages, and blood vessels by multiplex RNA in situ hybridization","volume":"35","author":"Ganier","year":"2022","journal-title":"Adv Skin Wound Care"},{"key":"10.1016\/j.coi.2025.102656_bib21","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/1346-8138.16672","article-title":"Prevalence of cutaneous manifestations in COVID-19: a meta-analysis","volume":"50","author":"Li","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2024.1390775","article-title":"Prevalence of skin manifestations in patients with COVID-19: a systematic review and meta-analysis","volume":"11","author":"de Aguiar","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2025.102656_bib23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/dermatopathology7010002","article-title":"Clinical and histopathological features and potential pathological mechanisms of skin lesions in COVID-19: review of the literature","volume":"7","author":"Kaya","year":"2020","journal-title":"Dermatopathology"},{"key":"10.1016\/j.coi.2025.102656_bib24","first-page":"e212","article-title":"Cutaneous manifestations in COVID-19: a first perspective","volume":"34","author":"Recalcati","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2025.102656_bib25","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s13555-021-00526-8","article-title":"Time of onset of selected skin lesions associated with COVID-19: a systematic review","volume":"11","author":"Gisondi","year":"2021","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.coi.2025.102656_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galvan Casas","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jaad.2020.05.073","article-title":"Cutaneous manifestations related to coronavirus disease 2019 (COVID-19): a prospective study from China and Italy","volume":"83","author":"De Giorgi","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaad.2020.04.044","article-title":"Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients","volume":"83","author":"Marzano","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102656_sbref29","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19-associated dermatologic manifestations: an international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jaad.2020.05.109","article-title":"Pernio-like skin lesions associated with COVID-19: a case series of 318 patients from 8 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib31","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14312","article-title":"Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19","volume":"33","author":"Gallizzi","year":"2020","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.coi.2025.102656_bib32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/bjd.20707","article-title":"Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak","volume":"185","author":"Frumholtz","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib33","first-page":"646","article-title":"COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2","volume":"17","author":"Yatim","year":"2021","journal-title":"Rev Med Suisse"},{"key":"10.1016\/j.coi.2025.102656_bib34","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.coi.2025.102656_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110525","article-title":"Pandemic-associated pernio harbors footprints of an abortive SARS-CoV-2 infection","volume":"27","author":"Arkin","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.coi.2025.102656_bib36","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jid.2023.07.018","article-title":"SARS-CoV-2-induced vasculitic skin lesions are associated with massive spike protein depositions in autophagosomes","volume":"144","author":"Gawaz","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41115-3","article-title":"SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication","volume":"13","author":"Montezano","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2025.102656_bib38","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.coi.2025.102656_bib39","article-title":"SARS-CoV-2 spike protein induces IL-18-mediated cardiopulmonary inflammation via reduced mitophagy","volume":"8","author":"Liang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.coi.2025.102656_bib40","article-title":"Viral afterlife: SARS-CoV-2 as a reservoir of immunomimetic peptides that reassemble into proinflammatory supramolecular complexes","volume":"121","author":"Zhang","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2025.102656_bib41","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2012-01-401364","article-title":"Cytosolic sensing of extracellular self-DNA transported into monocytes by the antimicrobial peptide LL37","volume":"120","author":"Chamilos","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coi.2025.102656_sbref42","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231467","article-title":"Enhanced TLR7-dependent production of type I interferon by pDCs underlies pandemic chilblains","volume":"222","author":"Saidoune","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102656_bib43","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20101102","article-title":"Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons","volume":"207","author":"Gregorio","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2025.102656_bib44","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41590-020-0721-6","article-title":"The commensal skin microbiota triggers type I IFN-dependent innate repair responses in injured skin","volume":"21","author":"Di Domizio","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2025.102656_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104241","article-title":"The impact of TLR7 agonist R848 treatment on mast cell phenotype and activity","volume":"359","author":"Agier","year":"2021","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coi.2025.102656_bib46","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","article-title":"Long COVID: major findings, mechanisms and recommendations","volume":"21","author":"Davis","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coi.2025.102656_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1473-3099(20)30986-5","article-title":"Long COVID in the skin: a registry analysis of COVID-19 dermatological duration","volume":"21","author":"McMahon","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2025.102656_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(21)00133-X","article-title":"Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy","volume":"21","author":"Mehta","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2025.102656_bib49","article-title":"Dermatological complications due to post\u2011COVID\u201119 syndrome: a systematic review","volume":"5","author":"Cayon Figueroa","year":"2025","journal-title":"Med Int"},{"key":"10.1016\/j.coi.2025.102656_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/v14071415","article-title":"Potential autoimmunity resulting from molecular mimicry between SARS-CoV-2 spike and human proteins","volume":"14","author":"Nunez-Castilla","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2025.102656_bib51","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1016\/S2666-5247(22)00390-1","article-title":"Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials","volume":"4","author":"Yang","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.coi.2025.102656_bib52","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1074\/jbc.M115.683011","article-title":"Identification of QS-21 as an inflammasome-activating molecular component of saponin adjuvants","volume":"291","author":"Marty-Roix","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2025.102656_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines12010083","article-title":"Burden and impact of reactogenicity among adults receiving COVID-19 vaccines in the United States and Canada: results from a prospective observational study","volume":"12","author":"Rousculp","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.coi.2025.102656_bib54","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2025.102656_bib55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/exd.14793","article-title":"Do different platforms of coronavirus vaccines have different impacts on psoriasis flares?","volume":"32","author":"Chularojanamontri","year":"2023","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib56","first-page":"853","article-title":"Autoimmune skin disorders and SARS-CoV-2 vaccination \u2014 a meta-analysis","volume":"21","author":"Hinterseher","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.coi.2025.102656_bib57","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jdcr.2021.02.014","article-title":"\"COVID arm\": a reaction to the Moderna vaccine","volume":"10","author":"Wei","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.coi.2025.102656_sbref58","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/bjd.20639","article-title":"Cutaneous reactions after SARS-CoV-2 vaccination: a cross-sectional Spanish nationwide study of 405 cases","volume":"186","author":"Catala","year":"2022","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122048","article-title":"Study of excipients in delayed skin reactions to mRNA vaccines: positive delayed intradermal reactions to polyethylene glycol provide new insights for COVID-19 arm","volume":"10","author":"Pesque","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.coi.2025.102656_bib60","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11050915","article-title":"Polyethylene glycol and polysorbate 80 skin tests in the context of an allergic risk assessment for hypersensitivity reactions to anti-SARS-CoV-2 mRNA vaccines","volume":"11","author":"Nappi","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.coi.2025.102656_bib61","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s40257-022-00721-z","article-title":"New onset and exacerbations of psoriasis following COVID-19 vaccines: a systematic review","volume":"23","author":"Wu","year":"2022","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jdv.17744","article-title":"Cutaneous findings following COVID-19 vaccination: review of world literature and own experience","volume":"36","author":"Gambichler","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2025.102656_bib63","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/1346-8138.16799","article-title":"COVID-19 vaccine-associated vitiligo: a cross-sectional study in a tertiary referral center and systematic review","volume":"50","author":"Tsai","year":"2023","journal-title":"J Dermatol"},{"key":"10.1016\/j.coi.2025.102656_bib64","doi-asserted-by":"crossref","DOI":"10.1186\/s40001-024-01956-8","article-title":"Alopecia areata following COVID-19 vaccine: a systematic review","volume":"29","author":"Zhu","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.coi.2025.102656_bib65","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"10.1016\/j.coi.2025.102656_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-024-01966-9","article-title":"SARS-CoV-2 and its ORF3a, E and M viroporins activate inflammasome in human macrophages and induce of IL-1alpha in pulmonary epithelial and endothelial cells","volume":"10","author":"Ambrozek-Latecka","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.coi.2025.102656_bib67","article-title":"SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation","volume":"12","author":"Pan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2025.102656_bib68","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1038\/s41380-022-01831-0","article-title":"SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein","volume":"28","author":"Albornoz","year":"2023","journal-title":"Mol Psychiatry"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791525001323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T08:37:59Z","timestamp":1775032679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791525001323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":68,"alternative-id":["S0952791525001323"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2025.102656","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin manifestations of SARS-CoV-2 infection and its vaccination","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2025.102656","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102656"}}